MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Clinical profile of Parkinson’s disease at the neurology department of Point G Teaching Hospital

    T. Coulibaly, A.S. Sissoko, T. Coulibaly, L. Guida, K. Mamadou, G.C. Oumar (Bamako, Mali)

    Objective: To determine the frequency and clinical features of PD at the neurology department of Point G Teaching Hospital. Background: PD results from loss of…
  • 2016 International Congress

    Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

    J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

    Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…
  • 2016 International Congress

    Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

    L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)

    Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…
  • 2016 International Congress

    The role of diabetes mellitus and hyperglycemia in early de novo Parkinson’s disease patients

    S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)

    Objective: To investigate the impact of diabetes mellitus (DM) and hyperglycemia in early de novo (untreated) Parkinson's disease (PD) patients. Background: Patients affected by DM…
  • 2016 International Congress

    Impact of a holistic and interdisciplinary care for patients with Parkinson’s disease – Cologne Parkinson’s network. Results of a randomized study with subanalysis

    R.A. Dano, J. Schill, L. Rochhausen, K. Williamson, L. Timmermann, C. Eggers (Cologne, Germany)

    Objective: This study aimed to verify that an intensive care with a dynamic team (neurologist, nurse) is able to improve the quality of life (QoL)…
  • 2016 International Congress

    Motivators and barriers to participation in exercise in Parkinson’s disease

    M. Afshari, Y. Kianirad, D. Bega (Chicago, IL, USA)

    Objective: To understand exercise habits, motivators, and barriers to exercise among PD patients. Background: Despite a large body of literature demonstrating the benefits of physical…
  • 2016 International Congress

    Evaluating Parkinsonian motor features via the routine use of consumer electronics – neuroQWERTY

    Á. Sánchez-Ferro, C.S. Mendoza, I. Butterworth, M. Matarazzo, P. Montero, R. Trincado, T. Arroyo Gallego, V. Puertas Martín, M.J. Catalán, J.A. Molina, F. Bermejo-Pareja, L. Giancardo (Móstoles, Spain)

    Objective: Our goal was to evaluate the validity and reproducibility of a novel metric, neuroQWERTY index (nQi), to characterize PD's motor component. Background: The motor…
  • 2016 International Congress

    The Faroese Parkinson’s diseases research program-Multifactorial analyses of a complex syndrome

    M.S. Petersen, S. Bech, E. Nosova, L.L. Farrell, I. Guella, D. Evans, B. Ritz, J. Aasly, M.J. Farrer (Tórshavn, Faroe Islands)

    Objective: The program aim is to assess the contribution of genes and environment influencing susceptibility, progression and the relative contribution of risk factors underlying Parkinson's…
  • 2016 International Congress

    Analysis of the genetic variability in Parkinson’s disease from southern Spain

    S. Bandres-Ciga, N.E. Mencacci, R. Durán, F.J. Barrero Hernández, F. Escamilla-Sevilla, S. Morgan, J. Hehir, F. Vives, J. Hardy, A.M. Pittman (Granada, Spain)

    Objective: Our study was to assess the contribution of known genes in a cohort diagnosed with either familial (FPD) or early-onset sporadic PD (EOPD) from…
  • 2016 International Congress

    Alpha-synuclein gene variants may predict neurostimulation outcome

    D. Weiss, S. Herrmann, L. Wang, C. Schulte, K. Brockmann, C. Plewnia, T. Gasser, M. Sharma, A. Gharabaghi, R. Krüger (Tübingen, Germany)

    Objective: We aim to predict both treatment efficacy and disease progression in PD patients with subthalamic nucleus deep brain stimulation therapy (STN-DBS) by genotyping of…
  • « Previous Page
  • 1
  • …
  • 383
  • 384
  • 385
  • 386
  • 387
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley